Investing.com - Redhill ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Redhill ADR announced earnings per share of $0.05 on revenue of $20.57M. Analysts polled by Investing.com anticipated EPS of $-0.422 on revenue of $22.59M.
Redhill ADR shares are down 12.75% from the beginning of the year, still down 38.70% from its 52 week high of $11.50 set on February 22. They are under-performing the Nasdaq which is up 6.59% from the start of the year.
Redhill ADR shares gained 1.84% in pre-market trade following the report.
Redhill ADR follows other major Healthcare sector earnings this month
Redhill ADR's report follows an earnings beat by Pfizer on May 4, who reported EPS of $0.93 on revenue of $14.58B, compared to forecasts EPS of $0.7759 on revenue of $13.65B.
AbbVie had beat expectations on April 30 with first quarter EPS of $2.95 on revenue of $13.01B, compared to forecast for EPS of $2.81 on revenue of $12.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar